News & Updates
Filter by Specialty:
Are pregnant women with rheumatic disease at risk of poor COVID-19 outcomes?
20 Jan 2022
byStephen Padilla
Pregnant women with rheumatic disease and COVID-19 show favourable outcomes, but data are limited by the small sample size and methodology, reports a study.
Are pregnant women with rheumatic disease at risk of poor COVID-19 outcomes?
20 Jan 2022Sitafloxacin a promising treatment alternative for UTI
20 Jan 2022
byAudrey Abella
Oral sitafloxacin was just as effective and safe as levofloxacin for the treatment of complicated and uncomplicated urinary tract infections (UTIs) in adults, according to a phase III study from China.
Sitafloxacin a promising treatment alternative for UTI
20 Jan 2022Fulvestrant-palbociclib combo pre-progression improves PFS in ESR1+ mBC
12 Jan 2022
byRoshini Claire Anthony
Switching to a fulvestrant-palbociclib regimen prior to disease progression after detection of elevated ESR1 mutations in the blood of patients with hormone receptor-positive (HR+), HER2-negative (HER2-) metastatic breast cancer (mBC) who were receiving aromatase inhibitors (AIs) plus palbociclib extended their progression-free survival (PFS), results of the phase III PADA-1 trial showed.